Morgan Stanley on Seagen (SGEN): 'We believe the reported ORR is at the high-end of investor expectations and should drive SGEN ~3-5%+ higher'
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating and $180.00 price target on Seagen (NASDAQ: SGEN).The analyst comments "64.5 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
